Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

BioLineRx (BLRX) Gross Profit: 2012-2024

Historic Gross Profit for BioLineRx (BLRX) over the last 13 years, with Dec 2024 value amounting to $19.7 million.

  • BioLineRx's Gross Profit fell 94.84% to $232,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $10.2 million, marking a year-over-year increase of 4.42%. This contributed to the annual value of $19.7 million for FY2024, which is 1675.90% up from last year.
  • According to the latest figures from FY2024, BioLineRx's Gross Profit is $19.7 million, which was up 1,675.90% from $1.1 million recorded in FY2023.
  • BioLineRx's Gross Profit's 5-year high stood at $19.7 million during FY2024, with a 5-year trough of $1.0 million in FY2021.
  • Over the past 3 years, BioLineRx's median Gross Profit value was $2.2 million (recorded in 2022), while the average stood at $7.6 million.
  • Per our database at Business Quant, BioLineRx's Gross Profit crashed by 48.66% in 2023 and then spiked by 1,675.90% in 2024.
  • BioLineRx's Gross Profit (Yearly) stood at $1.6 million in 2020, then slumped by 38.24% to $1.0 million in 2021, then skyrocketed by 114.51% to $2.2 million in 2022, then slumped by 48.66% to $1.1 million in 2023, then spiked by 1,675.90% to $19.7 million in 2024.